Article PDF
References
Weistat-Saslow, D. et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257–1260 (1995).
Keyomarsi, K. & Pardee, A.B. Redundant cyclin over-expression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA 90, 1112–1116 (1993).
Keyomarsi, K. et al. Cyclin E a potential prognostic marker for breast cancer. Cancer Res. 54, 380–385 (1994).
Dutta, A., Chandra, R., Leiter, L.M. & Lester, S. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proc Natl. Acad. Sci. USA 92, 5386–5390 (1995).
Keyomarsi, K., Conte, D., Toyofuku, W. & Pat Fox, M. Deregulation of cyclin E in breast cancer. Oncogene 11, 941–950 (1995).
Pardee, A.B. G1 events and regulation of cell proliferation. Science 246, 603–608 (1989).
Dou, Q-P., Levin, A.H., Zhao, S. & Pardee, A.B. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 53, 1493–1497 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steeg, P. Reply to “Cyclin E — a better prognostic marker for breast cancer than cyclin D?”. Nat Med 2, 254 (1996). https://doi.org/10.1038/nm0396-254b
Issue Date:
DOI: https://doi.org/10.1038/nm0396-254b